Company Peloton Therapeutics, Inc.
Equities
PLTX
US70614L1044
Biotechnology & Medical Research
Business Summary
Number of employees: 64
Managers
Managers | Title | Age | Since |
---|---|---|---|
Naseem Zojwalla
CTO | Chief Tech/Sci/R&D Officer | 51 | - |
Corporate Officer/Principal | - | - | |
Peter Stenge
PRN | Corporate Officer/Principal | - | - |
Bronson Crouch
PRN | Corporate Officer/Principal | 51 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Helen Kim
BRD | Director/Board Member | 61 | 01/17/01 |
Brett A. Ringle
BRD | Director/Board Member | 73 | 01/11/01 |
David Chang
BRD | Director/Board Member | 64 | 01/18/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 44,461,361 | 0 | 0 | - |
Company contact information
Peloton Therapeutics, Inc.
2330 Inwood Road Suite 226
75235-7323, Dallas
+
http://www.pelotontherapeutics.com![address Peloton Therapeutics, Inc.(PLTX)](https://cdn.zonebourse.com/static/address/58808515.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+16.13% | 122B | |
+19.65% | 113B | |
+21.22% | 26.49B | |
-23.84% | 19.4B | |
-17.47% | 16.24B | |
-45.95% | 15.15B | |
-19.28% | 15.4B | |
+63.81% | 14.93B | |
+1.94% | 13.52B |